Comprehensive genomic profiling of clinically relevant cancer genes with Illumina's TruSight Oncology 500 (TSO 500) NGS assay

Our TSO whitepaper explores proprietary bioinformatic workflows coupled with Dragen and Illumina Connected Insights for data analysis. The approach ensures high sensitivity and specificity, delivering a comprehensive cancer genomic profile tailored to your samples.